Your browser doesn't support javascript.
loading
Single Center Experience (Ten Years) with Surgical Resection for Treating Hepatocellular Carcinoma: Strategies for improving the long-term survival after resection
Article de Ko | WPRIM | ID: wpr-98947
Bibliothèque responsable: WPRO
ABSTRACT
PURPOSE: Although surgical resection is the most effective treatment for hepatocellular carcinoma (HCC), high recurrence after resection is a major challenging problem. We attempted to determine the optimal strategies for improving the long-term surgical outcome through the review of our 10 years' experience with surgically treating HCC. METHODS: We retrospectively reviewed 497 patients who received curative resection at the Yonsei University Health System from January 1996 to August 2006. RESULTS: The 5 year disease-free rate and the overall survival rate after curative resection were 45.0% and 63.9%, respectively. Of the 497 patients, 491 (98.8%) were Child-Pugh A and 107 (56.3%) were diagnosed with liver cirrhosis. The postoperative complication and mortality rates were 28.6% and 1.8%, respectively. Of the 243 recurrent patients, 184 (75.7%) were diagnosed with intrahepatic recurrence alone. Of these intrahepatic recurrent patients, 169 (91.9%) received active treatment, including transplantation (n=7), re-resection (n=12), local ablation therapy (n=18) and transarterial chemoembolization (n=132). Multivariate analysis revealed that perioperative transfusion, a satellite nodule, the pathologic TNM stage, the Edmondsons-Steiner grade, the serum alkaline phosphatase (ALP) and aspartate aminotransferase levels and cirrhosis were associated with disease free survival, and perioperative transfusion, a satellite nodule, macroscopic vascular invasion, the Edmondsons-Steiner grade, the ALP and serum albumin levels and the platelet count were related with overall survival after resection. CONCLUSIONS: The long-term surgical outcome of HCC can be further improved by proper patient selection, delicately performed surgery and administering postoperative adjuvant therapy for patients with a high risk of recurrence. Early diagnosis and aggressive treatment are needed to treat the recurrence
Sujet(s)
Mots clés
Texte intégral: 1 Indice: WPRIM Sujet Principal: Numération des plaquettes / Complications postopératoires / Aspartate aminotransferases / Récidive / Fibrose / Sérumalbumine / Analyse multifactorielle / Taux de survie / Études rétrospectives / Carcinome hépatocellulaire Type d'étude: Diagnostic_studies / Observational_studies / Screening_studies Limites du sujet: Humans langue: Ko Texte intégral: Korean Journal of Hepato-Biliary-Pancreatic Surgery Année: 2008 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Numération des plaquettes / Complications postopératoires / Aspartate aminotransferases / Récidive / Fibrose / Sérumalbumine / Analyse multifactorielle / Taux de survie / Études rétrospectives / Carcinome hépatocellulaire Type d'étude: Diagnostic_studies / Observational_studies / Screening_studies Limites du sujet: Humans langue: Ko Texte intégral: Korean Journal of Hepato-Biliary-Pancreatic Surgery Année: 2008 Type: Article